Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SI9L
|
|||
| Drug Name |
Nicotinamide riboside
|
|||
| Synonyms |
nicotinamide riboside; nicotinamide ribose; nicotinamide-beta-riboside; nicotinamide ribonucleoside; N-ribosylnicotinamide; 1341-23-7; ribosylnicotinamide; 1-(beta-D-Ribofuranosyl)nicotinamide; UNII-0I8H2M0L7N; 0I8H2M0L7N; CHEBI:15927; 3-Carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium; SRT647; SRT-647; SRT 647; N-ribosyl-nicotinamide; AC1L98BO; beta-nicotinamide D-riboside; SCHEMBL938611; N-Ribosyl-Nicotinamide New; Pyridinium, 3-(aminocarbonyl)-1-beta-D-ribofuranosyl-; CHEMBL43849
Click to Show/Hide
|
|||
| Indication | Mitochondrial myopathy [ICD-11: 8C73; ICD-10: G71.3] | Phase 1 | [1] | |
| Company |
ChromaDex Irvine, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H15N2O5+
|
|||
| Canonical SMILES |
C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N
|
|||
| InChI |
1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1
|
|||
| InChIKey |
JLEBZPBDRKPWTD-TURQNECASA-O
|
|||
| CAS Number |
CAS 1341-23-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:15927
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.